IndiaMart
FIEO
Anti-hyperlipidemic APIs are used to manage high cholesterol and triglyceride levels, reducing cardiovascular risk. BLUEPILL EXPRESS offers WHO-GMP certified bulk manufacturing and supply of high-quality anti-hyperlipidemic APIs for global pharmaceutical companies.
Anti-hyperlipidemic agents are a vital class of medications that help regulate lipid levels in the bloodstream, thereby preventing and managing cardiovascular diseases such as atherosclerosis, coronary artery disease, and stroke. These APIs work by lowering LDL cholesterol, triglycerides, and total cholesterol, and in some cases, increasing HDL (good cholesterol).
At BLUEPILL EXPRESS, we offer comprehensive third-party manufacturing solutions for a wide range of anti-hyperlipidemic APIs, ensuring global compliance, batch consistency, and cost-effectiveness. Our manufacturing facilities are WHO-GMP, ISO 9001:2015 certified and designed to meet the regulatory requirements of international markets across Asia, Africa, Latin America, the Middle East, and the CIS region.
- Pharmacopeial standards (IP/BP/USP/EP compliant)
- High-purity APIs with validated manufacturing processes
- In-house quality testing for assay, stability, and impurity profiling
- Full technical documentation: COA, MSDS, stability data, and more
- Custom bulk packaging with export documentation support
BLUEPILL EXPRESS is equipped to handle large-scale production as well as customized small batches, offering flexibility and speed-to-market for pharmaceutical brands, distributors, and government healthcare procurement agencies.
- Hypercholesterolemia
- Mixed Dyslipidemia
- Hypertriglyceridemia
- Cardiovascular risk reduction in diabetic and hypertensive patients
As cardiovascular disease remains one of the leading causes of mortality worldwide, the demand for anti-hyperlipidemic medications continues to rise. BLUEPILL EXPRESS supports this demand by delivering reliable, high-quality APIs that meet international therapeutic standards.
